Estimating Long-Term Survival of Adults with Philadelphia Chromosome-Negative Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia Treated with Blinatumomab Using Historical Data

被引：0

作者：

Arie Barlev

Vincent W. Lin

Aaron Katz

Kuolung Hu

Ze Cong

Beth Barber

机构：

[1] Global Health Economics,

[2] Amgen Inc.,undefined

[3] Center for Observational Research,undefined

[4] Amgen Inc.,undefined

[5] Global Biostatistical Science,undefined

[6] Amgen Inc.,undefined

来源：

Advances in Therapy | 2017年 / 34卷

关键词：

Acute lymphoblastic leukemia; Blinatumomab; Hematology; Long-term survival; Oncology;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：148 / 155

页数：7

共 44 条

[31] High-Dose Vincristine Sulfate Liposome Injection, for Advanced, Relapsed, or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in an Adolescent and Young Adult Subgroup of a Phase 2 Clinical Trial [J].

Schiller, Gary J. ;

Damon, Lloyd E. ;

Coutre, Steven E. ;

Hsu, Pamela ;

Bhat, Gajanan ;

Douer, Dan .

JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2018, 7 (05) :546-552

[32] Long-term survival and proliferation of precursor-B acute lymphoblastic leukemia cells on human bone marrow stroma [J].

Bradstock, K ;

Bianchi, A ;

Makrynikola, V ;

Filshie, R ;

Gottlieb, D .

LEUKEMIA, 1996, 10 (05) :813-820

[33] Retrospective chart review of hospitalizations and costs associated with the treatment of adults with Philadelphia-negative B-cell relapsed or refractory acute lymphoblastic leukemia in Belgium [J].

Maertens, Johan ;

Graux, Carlos ;

Breems, Dimitri ;

Havelange, Violaine ;

Wittnebel, Sebastian ;

Strens, Danielle ;

Hoefkens, Caroline .

ACTA CLINICA BELGICA, 2017, 72 (06) :429-433

[34] Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22+ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia [J].

Chevallier, Patrice ;

Leguay, Thibaut ;

Delord, Marc ;

Salek, Cyril ;

Kim, Rathana ;

Huguet, Francoise ;

Hicheri, Yosr ;

Wartiovaara-Kautto, Ulla ;

Raffoux, Emmanuel ;

Cluzeau, Thomas ;

Balsat, Marie ;

Roth-Guepin, Gabrielle ;

Tavernier, Emmanuelle ;

Lepretre, Stephane ;

Bilger, Karin ;

Bergugnat, Hugo ;

Berceanu, Ana ;

Alexis, Magda ;

Doubek, Michael ;

Brissot, Eolia ;

Hunault-Berger, Mathilde ;

Lebon, Delphine ;

Turlure, Pascal ;

Chantepie, Sylvain ;

Belhabri, Amine ;

Wickenhauser, Stefan ;

Bastie, Jean-Noel ;

Cacheux, Victoria ;

Himberlin, Chantal ;

Banos, Anne ;

Gardin, Claude ;

Bonnet, Sarah ;

Plantier, Isabelle ;

Pica, Gian Matteo ;

Escoffre-Barbe, Martine ;

Boissel, Nicolas ;

Dombret, Herve ;

Clappier, Emmanuelle ;

Rousselot, Philippe .

JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (36) :4327-4341

[35] Pretreatment blast-to-lymphocyte ratio as a prognostic marker for CD19/CD3-bispecific T cell-engaging antibodies (blinatumomab) treatment against relapsed or refractory B-precursor acute lymphoblastic leukemia [J].

Shimazu, Yutaka ;

Kitawaki, Toshio ;

Kondo, Tadakazu ;

Takaori-Kondo, Akifumi .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (11) :3861-3865

[36] Pretreatment blast-to-lymphocyte ratio as a prognostic marker for CD19/CD3-bispecific T cell-engaging antibodies (blinatumomab) treatment against relapsed or refractory B-precursor acute lymphoblastic leukemia [J].

Yutaka Shimazu ;

Toshio Kitawaki ;

Tadakazu Kondo ;

Akifumi Takaori-Kondo .

Cancer Immunology, Immunotherapy, 2023, 72 :3861-3865

[37] CAR-T Therapy Followed by Hematopoietic Stem Cell Transplantation Can Improve Survival in Children Relapsed/Refractory Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia [J].

Li, Yao ;

Hu, Guan-Hua ;

Xu, Lan-Ping ;

Zhang, Xiao-Hui ;

Liu, Kai-Yan ;

Suo, Pan ;

Wang, Yu ;

Cheng, Yi-Fei ;

Huang, Xiao-Jun .

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2024, 46 (05) :241-247

[38] Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial [J].

Jabbour, Elias ;

Short, Nicholas J. ;

Senapati, Jayastu ;

Jain, Nitin ;

Huang, Xuelin ;

Daver, Naval ;

DiNardo, Courtney ;

Pemmaraju, Naveen ;

Wierda, William ;

Garcia-Manero, Guillermo ;

Bravo, Guillermo Montalban ;

Sasaki, Koji ;

Kadia, Tapan M. ;

Khoury, Joseph ;

Wang, Sa A. ;

Haddad, Fadi G. ;

Jacob, Jovitta ;

Garris, Rebecca ;

Ravandi, Farhad ;

Kantarjian, Hagop M. .

LANCET HAEMATOLOGY, 2023, 10 (06) :E433-E444

[39] Estimating Long-Term Survival for Patients with Relapsed or Refractory Large B-Cell Lymphoma Treated with Chimeric Antigen Receptor Therapy: A Comparison of Standard and Mixture Cure Models [J].

Bansal, Aasthaa ;

Sullivan, Sean D. ;

Lin, Vincent W. ;

Purdum, Anna G. ;

Navale, Lynn ;

Cheng, Paul ;

Ramsey, Scott D. .

MEDICAL DECISION MAKING, 2019, 39 (03) :294-298

[40] INFUSION OF TUMOR-CONTAMINATED BONE-MARROW FOR AUTOLOGOUS RESCUE AFTER HIGH-DOSE THERAPY LEADING TO LONG-TERM REMISSION IN A PATIENT WITH RELAPSED PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA [J].

PETERS, SO ;

STOCKSCHLADER, M ;

HEGEWISCHBECKER, S ;

KRUGER, W ;

WEH, HJ ;

HOSSFELD, DK ;

ZANDER, AR .

BONE MARROW TRANSPLANTATION, 1995, 15 (05) :783-784

← 1 2 3 4 5 →